Author: News Room

Dublin, March 04, 2026 (GLOBE NEWSWIRE) — The “Inhaler Solution Market Size, Share & Trends Analysis Report by Inhaler Type (Pressurized Metered-Dose Inhalers (pMDIs), Dry-Powder Inhalers (DPIs)), Drug Class, Application, Distribution Channel, and Region with Growth Forecasts, 2026-2033” has been added to ResearchAndMarkets.com’s offering. The global inhaler solution market, valued at USD 31.42 billion in 2025, is projected to expand to USD 49.79 billion by 2033, with a CAGR of 5.9% from 2026 to 2033. This significant growth is fueled by a rise in respiratory disorders, such as asthma and chronic obstructive pulmonary disease, escalating air pollution, tobacco exposure, and…

Read More

“[Tech companies] need some PR help because people think that if a data center goes in, their electricity prices are going to go up,” Trump said during the event. “Some centers were rejected by communities for that and now I think it’s going to be the opposite.”“People think that if a data center goes in, their electricity prices are going to go up.”According to the proclamation, the seven companies present at the event have “accepted the terms of the Ratepayer Protection Pledge” and that “the commitments embodied therein effectuate the national policy of the United States.” It adds, however, that…

Read More

PayPal Investors With Significant Losses Are Encouraged To Contact Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson To Discuss Their Legal Rights If you purchased or acquired securities in PayPal between February 25, 2025 and February 2, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against PayPal Holdings, Inc. (“PayPal” or the “Company”) (NASDAQ:…

Read More

Dublin, March 04, 2026 (GLOBE NEWSWIRE) — The “Personalized Medicine Biomarkers Market Outlook 2026-2034: Market Share, and Growth Analysis” has been added to ResearchAndMarkets.com’s offering. The Personalized Medicine Biomarkers Market is forecasted to grow from USD 21.52 billion in 2025 to USD 58.25 billion by 2034, reflecting a CAGR of 11.7%. This market forms the backbone of precision healthcare, bridging molecular insights to therapeutic decisions, clinical trials, and disease monitoring. The predominant applications include oncology, with expansion into neurology, cardiometabolic, and autoimmune disease management. Driven by advancements such as next-generation sequencing and AI-driven analytics, the market sees demand from biopharma…

Read More

Navan Investors With Significant Losses Are Encouraged To Contact Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson To Discuss Their Legal Rights If you purchased or acquired securities in pursuant to and/or traceable to the Company’s Registration Statement and Prospectus (collectively, the “Offering Documents”) issued in connection with the Company’s IPO, on or about October 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP,…

Read More

Dublin, March 04, 2026 (GLOBE NEWSWIRE) — The “Non-Alcoholic Steatohepatitis Biomarkers Market Outlook 2026-2034: Market Share, and Growth Analysis” has been added to ResearchAndMarkets.com’s offering. The Non-Alcoholic Steatohepatitis (NASH) Biomarkers Market is poised for significant growth, with an estimated valuation of USD 1.57 billion in 2025, expanding at a CAGR of 24% to reach USD 10.88 billion by 2034. The market includes in-vitro assays, imaging modalities, and algorithmic composites that noninvasively detect steatohepatitis, stage fibrosis, and monitor therapeutic responses across clinical care and drug development. The market encompasses solutions such as routine lab analytes, proprietary serum panels, metabolomic and lipidomic…

Read More

Mereo BioPharma Investors With Significant Losses Are Encouraged To Contact Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson To Discuss Their Legal Rights If you purchased or acquired securities in Mereo between June 5, 2023 and December 26, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Mereo BioPharma Group plc (“Mereo” or the…

Read More

By Grace Miller Global News Posted March 4, 2026 7:51 pm 1 min read Descrease article font size Increase article font size A different man is facing a charge of manslaughter for the death of Kiefer Kitchemonia-Strongquill. Saskatoon police have charged a second person, 26-year-old Albert Scott, in connection with the city’s first homicide of the year.Scott faces charges of aggravated assault and manslaughter.Avyn Ahenakew, 18 years old, was arrested and charged with the same charges as Scott on Feb. 26. Get daily National news Get the day’s top news, political, economic, and current affairs headlines, delivered to your inbox…

Read More

Kyndryl Investors With Significant Losses Are Encouraged To Contact Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson To Discuss Their Legal Rights If you purchased or acquired securities in Kyndryl between August 7, 2024 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE:…

Read More

Epic CEO Tim Sweeney might be one of the most outspoken people in the history of the world. He fought two of the world’s most valuable and powerful companies almost all the way to the US Supreme Court, insulting them again and again: “crooked,” “deceitful,” “insanely sneaky,” calling Android a “fake open platform,” calling both companies “gangster-style businesses that will do anything they think they can get away with,” telling me how Google’s Project Hug was “an astonishingly corrupt effort at a massive scale.”On March 3rd, he not only signed away Epic’s rights to sue and disparage the company, he…

Read More